2013 LeIP Report Card on Lymphomas
One of the Lymphoma Coalition’s (LC) goals for the 2013 Lymphoma eInformation Project (LeIP) Report Card was to determine how patients with lymphoma are affected by the changes in healthcare. Specifically, we wanted to determine if patients with lymphoma receive therapy in the most cost-effective and timely manner. Through its research, the LC discovered that there are a myriad of barriers preventing therapies from reaching patients in a timely and cost-effective way. Systems (regulatory and funding) are often cumbersome, slow and difficult to access. Within countries, there are multiple layers of approvals with review bodies often appearing to be independent fiefdoms rather than cohesive units that can accept information from one body without having to undertake their own review of the same information. This contributes to enormous time lags between the submission of a drug for regulatory approval and then funding approval. Both regulatory and funding approval timelines can stretch into years.
Click the PDF below to read the 2013 LeIP Report Card on Lymphomas.
2013 LeIP Report Card on Lymphomas (765.14 kB)
Click on the PDF below to read the Therapy Approval Process Situation Analysis 2013.
Therapy Approval Process Situation Analysis 2013 (883.22 kB)
Click on the PDF below to download the Regulatory Funding Website Resouce Chart.
Click on the PDF below to download the EMA Regulatory Process Flowchart.
Click on the PDF below to download the Country Regulatory Comparison Matrix.
Click on the PDFs below to download the Funding Process Flowchart for each country.
France Funding Process Flowchart - October 2013 (464.51 kB)